CUAMC
ADVM

China Universal Asset Management Company’s Adverum Biotechnologies ADVM Stock Holding History

China Universal Asset Management Company’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-93
Closed -$1K – 394
2022
Q3 		$1K Buy
+93
New +$1.22K ﹤0.01% 378

Other funds holding ADVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
SGL
Sonic GP LLC Honolulu, Hawaii $45.4M AUM 5.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

China Universal Asset Management Company's ADVM Position: Q4 2022 in Review

China Universal Asset Management Company sold out of Adverum Biotechnologies (ADVM) in Q4 2022, closing a stake of 93 shares — an estimated $1K sold.

China Universal Asset Management Company first reported a position in ADVM in Q3 2022 and held it in 1 quarter. The position peaked at $1K in Q3 2022. 59 funds tracked by Wall St. Rank hold ADVM as of Q4 2022.

  • China Universal Asset Management Company reported no remaining Adverum Biotechnologies position as of Q4 2022 after selling out during the quarter.
  • China Universal Asset Management Company sold 93 Adverum Biotechnologies shares in Q4 2022, an estimated $1K.
  • China Universal Asset Management Company first reported a position in Adverum Biotechnologies in Q3 2022 and held it in 1 quarter.
  • China Universal Asset Management Company's Adverum Biotechnologies position peaked at $1K in Q3 2022.
  • 59 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2022.

Based on China Universal Asset Management Company's 13F filing for Q4 2022, filed 31 Jan 2023.